Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2022-02-09 10:24 am Sale | 2022-02-08 | 13G | Royalty Pharma plc RPRX | FMR LLC | 22,079,795 5.140% | -2,862,750 (-11.48%) | Filing History |
| 2021-02-12 7:11 pm Purchase | 2020-12-31 | 13G | Royalty Pharma plc RPRX | GENERAL ATLANTIC L.P. | 26,243,870 6.400% | 26,243,870 (New Position) | Filing History |
| 2021-02-11 07:52 am Sale | 2020-12-31 | 13G | Royalty Pharma plc RPRX | ADAGE CAPITAL PARTNERS GP L.L.C. | 38,714,280 9.970% | -7,301,050 (-15.87%) | Filing History |
| 2021-02-10 4:05 pm Purchase | 2021-01-29 | 13G | Royalty Pharma plc RPRX | MORGAN STANLEY MS | 46,144,883 11.900% | 22,547,596 (+95.55%) | Filing History |
| 2021-02-09 4:53 pm Purchase | 2020-12-31 | 13G | Royalty Pharma plc RPRX | MORGAN STANLEY MS | 23,597,287 6.100% | 23,597,287 (New Position) | Filing History |
| 2021-02-08 10:31 am Purchase | 2021-02-05 | 13G | Royalty Pharma plc RPRX | FMR LLC | 24,942,545 6.426% | 24,942,545 (New Position) | Filing History |
| 2020-06-29 6:36 pm Purchase | 2020-06-18 | 13D | Royalty Pharma plc RPRX | Giuliani Mario Germano | 46,316,170 12.700% | 46,316,170 (New Position) | Filing History |
| 2020-06-24 4:54 pm Purchase | 2020-06-18 | 13G | Royalty Pharma plc RPRX | ADAGE CAPITAL PARTNERS GP L.L.C. | 46,015,330 12.580% | 46,015,330 (New Position) | Filing History |